Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Treatment Patterns and Unmet Need for Patients with Progressive Multiple Sclerosis in the United States: Survey Results from 2016 to 2021.
Journal: Neurology and therapy
Published: June 08, 2023
Results from Patient Interviews on Fatigue in Progressive Multiple Sclerosis and Evaluation of Fatigue Patient-Reported Outcome (PRO) Instruments.
Journal: Neurology and therapy
Published: December 17, 2021
Effectiveness of Dimethyl Fumarate in Patients With Relapsing Multiple Sclerosis Switching After Suboptimal Response to Glatiramer Acetate, Including Patients With Early Multiple Sclerosis: Subgroup Analysis of RESPOND.
Journal: Neurology and therapy
Published: September 07, 2020
Corrigendum to "Effectiveness of Delayed-release Dimethyl Fumarate on Clinical and Patient-reported Outcomes in Patients With Relapsing Multiple Sclerosis Switching From Glatiramer Acetate: RESPOND, a Prospective Observational Study" [Clinical Therapeutics 40 (12) (2018) 2077-2087].
Journal: Clinical therapeutics
Published: July 01, 2019
Comparative effectiveness of teriflunomide and dimethyl fumarate in patients with relapsing forms of MS in the retrospective real-world Teri-RADAR study.
Journal: Journal of comparative effectiveness research
Published: February 14, 2019
Reducing return of disease activity in patients with relapsing multiple sclerosis transitioned from natalizumab to teriflunomide: 12-month interim results of teriflunomide therapy.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: June 20, 2018
Outcomes of Stable Multiple Sclerosis Patients Staying on Initial Interferon Beta Therapy Versus Switching to Another Interferon Beta Therapy: A US Claims Database Study.
Journal: Advances in therapy
Published: May 24, 2018
Effectiveness of Delayed-release Dimethyl Fumarate on Clinical and Patient-reported Outcomes in Patients With Relapsing Multiple Sclerosis Switching From Glatiramer Acetate: RESPOND, a Prospective Observational Study.
Journal: Clinical therapeutics
Published: April 20, 2018
Development of a gait module to complement the 12-item Multiple Sclerosis Walking Scale: a mixed methods study.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: January 31, 2018
Addressing the targeting range of the ABILHAND-56 in relapsing-remitting multiple sclerosis: A mixed methods psychometric study.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: October 31, 2017
Last Updated: 09/26/2026